As thematic investors who assess global consumer spending trends, we have so many exciting secular trends to explore. One of the largest and most prominent consumption trends is the dramatic rise in Fintech innovation and the slow but steady death of cash as the primary method of transactions. Cash used as a percent of total global purchase transactions is estimated to be roughly 70% so it’s still very large.
As thematic investors who assess global consumer spending trends, we have so many exciting secular trends to explore. One of the largest and most prominent consumption trends is the dramatic rise in Fintech innovation and the slow but steady death of cash as the primary method of transactions. Cash used as a percent of total global purchase transactions is estimated to be roughly 70% so it’s still very large.
CIFC Asset Management’s Natalia Lojevsky and Stan Sokolowski provide their insights into the Fixed Income Markets, which have been experiencing an elevated bout of volatility as interest rates and inflation expectations have risen sharply. Stan and Natalia discuss the sea of red YTD for traditional fixed income returns and say we’re in a golden age for income producing alternatives.
CIFC Asset Management’s Natalia Lojevsky and Stan Sokolowski provide their insights into the Fixed Income Markets, which have been experiencing an elevated bout of volatility as interest rates and inflation expectations have risen sharply. Stan and Natalia discuss the sea of red YTD for traditional fixed income returns and say we’re in a golden age for income producing alternatives.
We are now, approximately one year from the start of the COVID-19 pandemic’s onset in the United States. In short, we remain in the midst of a stock market rotation away from “momentum” stocks fueled by COVID-related shutdowns and societal adaptations towards “value” stocks that remain historically cheap and consist of cyclical laggards.
Stereotaxis (NYSE: STXS) is the global leader in innovative tele-robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company’s surgical robotic system has been used by hundreds of leading physicians at over 100 hospitals globally and has treated over 100,000 patients with their technology.
Stereotaxis (NYSE: STXS) is the global leader in innovative tele-robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company’s surgical robotic system has been used by hundreds of leading physicians at over 100 hospitals globally and has treated over 100,000 patients with their technology.
There are several powerful mega-trends happening around the world. One of these trends is happening in the financial services industry and is still a game in the early innings.
Will Mag 7 stock Nvidia beat estimates? David Miller, Co-Founder and Chief Investment Officer of Catalyst Funds, Rational Funds, and Strategy Shares, provided his insights to CNBC on Nov. 19 on why he believes the company will come out ahead this week despite potentially challenging headlines.
In October, Goldman Sachs strategists cautioned investors to be prepared for stock market returns during the next decade that are toward the lower end of their typical performance distribution.